Rapid Detection of Panton-Valentine Leukocidin in Staphylococcus aureus Cultures by Use of a Lateral Flow Assay Based on Monoclonal Antibodies

Journal of Clinical Microbiology

Volumn 51, Issue 2, 2013, Pages 487-495

  Monecke, Stefan ^a,b   Müller, Elke ^a   Buechler, Joseph ^c   Rejman, John ^d   Stieber, Bettina ^a,b   Akpaka, Patrick Eberechi ^e   Bandt, Dirk ^f   Burris, Rob ^g   Coombs, Geoffrey ^h   Aida Hidalgo Arroyo, G ⁱ   Hughes, Peter ^j   Kearns, Angela ^k   Abós, Sonia Molinos ^l,m   Pichon, Bruno ^k   Skakni, Leila ⁿ   Söderquist, Bo ^o   Ehricht, Ralf ^a  

^a Alere Technologies GmbH   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Alere San Diego Inc   (United States)

^d Alere Scarborough Inc   (United States)

^e UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^f Institute for Medical Diagnostics Oderland   (Germany)

^g Alere Technologies GmbH   (Uganda)

^h CURTIN UNIVERSITY   (Australia)

ⁱ SOUTHMEAD HOSPITAL   (United Kingdom)

^j MEDICAL RESEARCH COUNCIL   (Uganda)

^k PUBLIC HEALTH ENGLAND   (United Kingdom)

^l HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^m UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

ⁿ KING FAHAD MEDICAL CITY   (Saudi Arabia)

^o ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PANTON VALENTINE LEUKOCIDIN;

AFRICA; ARTICLE; AUSTRALIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA MICROARRAY; EUROPE; GENOTYPE; IMMUNOASSAY; LATERAL FLOW ASSAY; LIMIT OF DETECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIDDLE EAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; WESTERN HEMISPHERE;

ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CELL SURFACE DISPLAY TECHNIQUES; EXOTOXINS; HUMANS; LEUKOCIDINS; PREVALENCE; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84873048428     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02285-12     Document Type: Article

References (32)

1. Jayasinghe L, Bayley H. 2005. The leukocidin pore: Evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis. Protein Sci. 14:2550 -2561.
2. Kaneko J, Kamio Y. 2004. Bacterial two-component and heteroheptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci. Biotechnol. Biochem. 68:981-1003.
3. Boyle-Vavra S, Daum RS. 2007. Community-acquired methicillinresistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab. Investig. 87:3-9.
4. Masiuk H, Kopron K, Grumann D, Goerke C, Kolata J, Jursa-Kulesza J, Giedrys-Kalemba S, Bröker BM, Holtfreter S. 2010. Association of recurrent furunculosis with Panton-Valentine Leukocidin and the genetic background of Staphylococcus aureus. J. Clin. Microbiol. 48:1527-1535.
5. Monecke S, Slickers P, Ellington M, Kearns A, Ehricht R. 2007. High diversity of Panton-Valentine leucocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated MRSA. Clin. Microbiol. Infect. 13:1157-1164.
6. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D, Etienne J. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759.
7. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, McDougal LK, Chaitram J, Jensen B, Fridkin SK, Killgore G, Tenover FC. 2006. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J. Infect. Dis. 193:172-179.
8. Megevand C, Gervaix A, Heininger U, Berger C, Aebi C, Vaudaux B, Kind C, Gnehm H-P, Hitzler M, Renzi G, Schrenzel J, Francois P. 2010. Molecular epidemiology of the nasal colonization by methicillinsusceptible Staphylococcus aureus in Swiss children. Clin. Microbiol. Infect. 16:1414 -1420.
9. Monecke S, Luedicke C, Slickers P, Ehricht R. 2009. Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur. J. Clin. Microbiol. Infect. Dis. 28:1159 -1165.
10. Ellington MJ, Hope R, Ganner M, East C, Brick G, Kearns AM. 2007. Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK? J. Antimicrob. Chemother. 60: 402-405.
11. Panton P, Valentine F. 1932. Staphylococcal toxin. Lancet i:506 -508.
12. Van de Velde H. 1894. Etude sur le mécanisme de la virulence du Staphylocoque pyogène. Cellule 10:401- 410.
13. CDC. 1999. Four pediatric deaths from community-acquired methicillinresistant Staphylococcus aureus-Minnesota and North Dakota. JAMA 282: 1123-1125.
14. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:978 -984.
15. Anjum MF, Tucker JD, Sprigings KA, Woodward MJ, Ehricht R. 2006. Use of miniaturized protein arrays for Escherichia coli O serotyping. Clin. Vaccine Immunol. 13:561-567.
16. Ehricht R, Adelhelm K, Monecke S, Huelseweh B. 2009. Application of protein array tubes to bacteria, toxin, and biological warfare agent detection. Methods Mol. Biol. 509:85-105.
17. Huelseweh B, Ehricht R, Marschall H. 2006. A simple and rapid protein array based method for the simultaneous detection of biowarfare agents. Proteomics 6:2972-2981.
18. Woelfl S, Dummer A, Pusch L, Pfalz M, Wang L, Clement J, Leube I, Ehricht R. 2004. Analyzing proteins and protein modifications with ArrayTube antibody microarrays, p 159-168. In Schena M (ed), Protein microarrays. Jones and Bartlett Publishers Sudbury, London, United Kingdom.
19. Nimmo GR, Coombs GW. 2008. Community-associated methicillinresistant Staphylococcus aureus (MRSA) in Australia. Int. J. Antimicrob. Agents 31:401- 410.
20. Coombs G, Monecke S, Pearson J, Tan H-L, Chew Y-K, Wilson L, Ehricht R, O'Brien F, Christiansen K. 2011. Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol. 11:215. doi:10.1186/1471-2180-11 -215.
21. Dunne WM Jr. 2006. Panton-Valentine leukocidin genes in a laboratory quality control strain of Staphylococcus aureus. J. Clin. Microbiol. 44:287.
22. Monecke S, Kuhnert P, Hotzel H, Slickers P, Ehricht R. 2007. Microarray- based study on virulence-associated genes and resistance determinants of Staphylococcus aureus isolates from cattle. Vet. Microbiol. 125: 128-140.
23. Schlotter K, Ehricht R, Hotzel H, Monecke S, Pfeffer M, Donat K. 2012. Leukocidin genes lukf-P83 and lukM are associated with Staphylococcus aureus clonal complexes 151, 479 and 133 isolated from bovine udder infections in Thuringia, Germany. Vet. Res. 43:42.
24. Noda M, Kato I. 1988. Purification and crystallization of staphylococcal leukocidin. Methods Enzymol. 165:22-32.
25. Monecke S, Slickers P, Hotzel H, Richter-Huhn G, Pohle M, Weber S, Witte W, Ehricht R. 2006. Microarray-based characterisation of a Panton- Valentine leukocidin-positive community-acquired strain of methicillin- resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12:718 -728.
26. Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Borg M, Chow H, Ip M, Jatzwauk L, Jonas D, Kadlec K, Kearns A, Laurent F, O'Brien FG, Pearson J, Ruppelt A, Schwarz S, Scicluna E, Slickers P, Tan H-L, Weber S, Ehricht R. 2011. A field guide to pandemic, epidemic and sporadic clones of methicillin- resistant Staphylococcus aureus. PLoS One 6:e17936. doi:10.1371/journal.pone. 0017936.
27. Monecke S, Slickers P, Ehricht R. 2008. Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition. FEMS Immunol. Med. Microbiol. 53:237-251.
28. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus Sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008 -1015.
29. Scicluna E, Shore A, Thuermer A, Ehricht R, Slickers P, Borg M, Coleman D, Monecke S. 2010. Characterisation of MRSA from Malta and the description of a Maltese epidemic MRSA strain. Eur. J. Clin. Microbiol. Infect. Dis. 29:163-170.
30. Boakes E, Kearns AM, Badiou C, Lina G, Hill RL, Ellington MJ. 2012. Do differences in Panton-Valentine leukocidin production among international methicillin-resistant Staphylococcus aureus clones affect disease presentation and severity? J. Clin. Microbiol. 50:1773-1776.
31. Monecke S, Buechler J, Ehricht R. 2011. Measuring S. aureus exotoxin concentrations using protein microarrays with antibodies generated by phage display. ECCMID, Milan, Italy.
32. Arias CA, Rincon S, Chowdhury S, Martinez E, Coronell W, Reyes J, Nallapareddy SR, Murray BE. 2008. MRSA USA300 clone and VREF-a U.S.-Colombian connection? N. Engl. J. Med. 359:2177-2179.